Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
October 23, 2020
Kinestral Technologies Appoints New Chief Executive Officer to Accelerate the Adoption of Halio Smart-Tinting Glass Globally
October 22, 2020
CinCor Pharma Announces First Patient Dosed with CIN-107 in Phase 2 Study in Treatment Resistant Hypertensive Subjects
October 22, 2020
IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform
October 22, 2020
Homology Medicines Unveils New In Vivo Gene Therapy Development Program for Hunter Syndrome
October 21, 2020
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020
October 21, 2020
Vor Biopharma Appoints Matthew R. Patterson to its Board of Directors
October 8, 2020
Impel Neuropharma Presents Data From Pivotal Phase 3 Registration Study of INP104 for the Treatment of Acute Migraine at 2020 Migraine Trust Virtual Symposium
October 5, 2020
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President
October 5, 2020
Magnetic Insight Awarded NIH SBIR grant to Advance In Vivo Biosensing Through Color Magnetic Particle Imaging
October 1, 2020
Akouos Announces Key Leadership Appointments
« Previous Page
1
…
48
49
50
51
52
…
118
Next Page »